SCHEMBL18746122

SCHEMBL18746122

CC1C(C)C1CC(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28737614 0.79 HSD11B1 (0.52) —
SCHEMBL1927992 0.75 HSD11B1 (0.44) —
SCHEMBL12993394 0.71 — —
SCHEMBL1861904 0.71 — —
SCHEMBL25678378 0.71 — —
SCHEMBL7145279 0.70 HSD11B1 (0.36) —
SCHEMBL1067170 0.67 HSD11B1 (0.61) —
SCHEMBL5411408 0.65 — —
SCHEMBL5411411 0.65 — —
SCHEMBL1251710 0.65 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170145032-A1 HETEROCYCLIC COMPOUNDS AND METHODS OF THEIR USE SPINIFEX PHARMACEUTICALS PTY LTD (AU) 2017-05-25 — — US disclosed
US-9624243-B2 Heterocyclic compounds and methods of their use NOVARTIS AG (CH) 2017-04-18 — — US disclosed
Send feedback